DK312583A - Kortikoidholdigt praeparat til topisk applikation - Google Patents

Kortikoidholdigt praeparat til topisk applikation Download PDF

Info

Publication number
DK312583A
DK312583A DK312583A DK312583A DK312583A DK 312583 A DK312583 A DK 312583A DK 312583 A DK312583 A DK 312583A DK 312583 A DK312583 A DK 312583A DK 312583 A DK312583 A DK 312583A
Authority
DK
Denmark
Prior art keywords
corticoid
emulsifier
water
phase
oil
Prior art date
Application number
DK312583A
Other languages
English (en)
Other versions
DK312583D0 (da
Inventor
Wolfgang Stindl
Ingfried Zimmermann
Renate Reckers
Hans Wendt
Rainold Arndt
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK312583D0 publication Critical patent/DK312583D0/da
Publication of DK312583A publication Critical patent/DK312583A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK312583A 1982-07-07 1983-07-06 Kortikoidholdigt praeparat til topisk applikation DK312583A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823225848 DE3225848A1 (de) 1982-07-07 1982-07-07 Kortikoidhaltige zubereitung zur topischen applikation

Publications (2)

Publication Number Publication Date
DK312583D0 DK312583D0 (da) 1983-07-06
DK312583A true DK312583A (da) 1984-01-08

Family

ID=6168121

Family Applications (1)

Application Number Title Priority Date Filing Date
DK312583A DK312583A (da) 1982-07-07 1983-07-06 Kortikoidholdigt praeparat til topisk applikation

Country Status (10)

Country Link
US (1) US4918065A (da)
EP (1) EP0098566B1 (da)
JP (1) JPS5976015A (da)
AT (1) ATE66366T1 (da)
AU (1) AU570639B2 (da)
CA (1) CA1202238A (da)
DE (2) DE3225848A1 (da)
DK (1) DK312583A (da)
GB (1) GB2123292A (da)
NZ (1) NZ204775A (da)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3225849A1 (de) * 1982-07-07 1984-01-19 Schering Ag Kortikoidhaltige zubereitung zur topischen applikation
JPS59137408A (ja) * 1983-01-27 1984-08-07 Taisho Pharmaceut Co Ltd 軟膏
JPS59139315A (ja) * 1983-01-31 1984-08-10 Taisho Pharmaceut Co Ltd クリ−ム剤
YU46838B (sh) * 1986-02-14 1994-06-24 Pero Dr. Višnjić Postupak za dobijanje preparata za lečenje kožne bolesti psoriazisa
DE3534742A1 (de) * 1985-09-28 1987-04-09 Beiersdorf Ag Hydrocortisondiester enthaltende w/o-creme
DE3534743A1 (de) * 1985-09-28 1987-04-02 Beiersdorf Ag Hydrocortisondiester enthaltende o/w-creme
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
US6001335A (en) * 1989-12-22 1999-12-14 Imarx Pharmaceutical Corp. Contrasting agents for ultrasonic imaging and methods for preparing the same
US6551576B1 (en) 1989-12-22 2003-04-22 Bristol-Myers Squibb Medical Imaging, Inc. Container with multi-phase composition for use in diagnostic and therapeutic applications
US5922304A (en) 1989-12-22 1999-07-13 Imarx Pharmaceutical Corp. Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
US5776429A (en) * 1989-12-22 1998-07-07 Imarx Pharmaceutical Corp. Method of preparing gas-filled microspheres using a lyophilized lipids
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5469854A (en) * 1989-12-22 1995-11-28 Imarx Pharmaceutical Corp. Methods of preparing gas-filled liposomes
US20020150539A1 (en) * 1989-12-22 2002-10-17 Unger Evan C. Ultrasound imaging and treatment
US5542935A (en) 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US6146657A (en) * 1989-12-22 2000-11-14 Imarx Pharmaceutical Corp. Gas-filled lipid spheres for use in diagnostic and therapeutic applications
US6088613A (en) 1989-12-22 2000-07-11 Imarx Pharmaceutical Corp. Method of magnetic resonance focused surgical and therapeutic ultrasound
GB9106686D0 (en) * 1991-03-28 1991-05-15 Hafslund Nycomed As Improvements in or relating to contrast agents
US5874062A (en) * 1991-04-05 1999-02-23 Imarx Pharmaceutical Corp. Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
DE59108924D1 (de) * 1991-07-16 1998-02-19 Schering Ag Verfahren zur herstellung von mikronisierte wirkstoffe enthaltende halbfeste zubereitungen
GB9200388D0 (en) * 1992-01-09 1992-02-26 Nycomed As Improvements in or relating to contrast agents
DE4333920A1 (de) * 1993-10-05 1995-04-13 Hoechst Ag Corticoid-17,21-dicarbonsäureester sowie Corticosteroid-17-carbonsäureester-21-kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US7083572B2 (en) * 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
US6743779B1 (en) 1994-11-29 2004-06-01 Imarx Pharmaceutical Corp. Methods for delivering compounds into a cell
US5830430A (en) * 1995-02-21 1998-11-03 Imarx Pharmaceutical Corp. Cationic lipids and the use thereof
US5632975A (en) * 1995-03-09 1997-05-27 Earles; R. Martin Composition and method for treatment of dermatitis on the scalp
US5997898A (en) * 1995-06-06 1999-12-07 Imarx Pharmaceutical Corp. Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
US6139819A (en) * 1995-06-07 2000-10-31 Imarx Pharmaceutical Corp. Targeted contrast agents for diagnostic and therapeutic use
US6231834B1 (en) 1995-06-07 2001-05-15 Imarx Pharmaceutical Corp. Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
US6033645A (en) * 1996-06-19 2000-03-07 Unger; Evan C. Methods for diagnostic imaging by regulating the administration rate of a contrast agent
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
EP0935415B1 (en) 1996-05-01 2006-11-22 Imarx Pharmaceutical Corp. In vitro methods for delivering nucleic acids into a cell
US6414139B1 (en) 1996-09-03 2002-07-02 Imarx Therapeutics, Inc. Silicon amphiphilic compounds and the use thereof
US5846517A (en) 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
DE69737915T2 (de) * 1996-09-11 2008-03-13 Bristol-Myers Squibb Medical Imaging, Inc. Verfahren zur diagnostischen Bilderzeugung der Nierenregion unter Verwendung eines Kontrastmittels und eines Vasodilators
US6143276A (en) * 1997-03-21 2000-11-07 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents to regions of elevated temperatures
US6090800A (en) * 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
US6537246B1 (en) * 1997-06-18 2003-03-25 Imarx Therapeutics, Inc. Oxygen delivery agents and uses for the same
US20050019266A1 (en) * 1997-05-06 2005-01-27 Unger Evan C. Novel targeted compositions for diagnostic and therapeutic use
US7452551B1 (en) 2000-10-30 2008-11-18 Imarx Therapeutics, Inc. Targeted compositions for diagnostic and therapeutic use
US6416740B1 (en) 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
US6548047B1 (en) 1997-09-15 2003-04-15 Bristol-Myers Squibb Medical Imaging, Inc. Thermal preactivation of gaseous precursor filled compositions
US6123923A (en) * 1997-12-18 2000-09-26 Imarx Pharmaceutical Corp. Optoacoustic contrast agents and methods for their use
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
US7208485B2 (en) * 2003-01-13 2007-04-24 Chemagis Ltd. Crystalline forms of halobetasol propionate
US20040138192A1 (en) * 2003-01-13 2004-07-15 Chemagis Ltd. Crystalline forms of halobetasol propionate
FR2856301B1 (fr) * 2003-06-23 2007-08-03 Galderma Res & Dev Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
EP2120868A4 (en) * 2007-04-11 2010-08-25 Perrigo Israel Phamaceuticals LOW-DOSED MOMETASON FORMULATIONS
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US8962028B2 (en) * 2012-10-18 2015-02-24 MiCal Pharmaceuticals LLC—H Series, a Series of MiCal Pharmaceuticals LLC, a Multi-Division Limited Liability Company Topical steroid composition and method
LT3310389T (lt) 2015-06-18 2020-11-10 Bausch Health Ireland Limited Vietinio vartojimo kompozicijos, apimančios kortikosteroidą ir retinoidą, skirtos psoriazės gydymui
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1106455B (de) * 1959-05-29 1961-05-10 Upjohn Co Salbengrundlage
GB1013180A (en) * 1962-10-30 1965-12-15 Ici Ltd Steroid compositions
FI44459B (da) * 1968-10-25 1971-08-02 K Rehtijaervi
FR2112147B1 (da) * 1970-11-09 1975-01-10 Wenmaekers Paul
CH566787A5 (da) * 1972-06-09 1975-09-30 Herzog Paul
GB1478009A (en) * 1973-04-02 1977-06-29 Glaxo Lab Ltd Pharmaceutical compositions
US4115313A (en) * 1974-10-08 1978-09-19 Irving Lyon Bile acid emulsions
DE2514873C2 (de) * 1975-04-05 1983-12-29 Merck Patent Gmbh, 6100 Darmstadt Salbengrundlage
US4070462A (en) * 1976-10-26 1978-01-24 Schering Corporation Steroid ointment
US4284630A (en) * 1978-03-22 1981-08-18 Yu Ruey J Stabilized water-in-oil emulsions
JPS56135416A (en) * 1980-03-27 1981-10-22 Mitsubishi Chem Ind Ltd Pharmaceutical preparation for skin
SE8004580L (sv) * 1980-06-19 1981-12-20 Draco Ab Farmaceutisk beredning
GB2084465B (en) * 1980-10-06 1984-09-12 Glaxo Group Ltd Topically administrable pharmaceutical compositions containing anti-inflammatory steroids
ATA207181A (de) * 1981-05-08 1983-09-15 Schering Wien Kosmetisches mittel und verfahren zu seiner herstellung
DE3225849A1 (de) * 1982-07-07 1984-01-19 Schering Ag Kortikoidhaltige zubereitung zur topischen applikation

Also Published As

Publication number Publication date
GB8318396D0 (en) 1983-08-10
DE3382378D1 (de) 1991-09-26
NZ204775A (en) 1986-03-14
DK312583D0 (da) 1983-07-06
AU1647083A (en) 1984-01-12
ATE66366T1 (de) 1991-09-15
EP0098566A3 (en) 1985-05-22
CA1202238A (en) 1986-03-25
EP0098566B1 (de) 1991-08-21
AU570639B2 (en) 1988-03-24
DE3225848A1 (de) 1984-01-19
US4918065A (en) 1990-04-17
EP0098566A2 (de) 1984-01-18
JPS5976015A (ja) 1984-04-28
GB2123292A (en) 1984-02-01

Similar Documents

Publication Publication Date Title
DK312583A (da) Kortikoidholdigt praeparat til topisk applikation
DK0797432T3 (da) Olie-i-vand-emulsioner
KR840006440A (ko) 국소 외용 약학적 조성물의 제조방법
DE3168085D1 (en) Water-in-oil emulsion spread having a fat content ranging from 25 to 65 wt%, which comprises a dispersed aqueous phase containing a gelling system
KR950007831A (ko) 세라미드와 리놀렌산을 혼합한 신규 화장제 및 피부학적 조성물, 및 그의 제법
KR840006280A (ko) α-시아노-3-페녹시-4-플루오로벤질 2'2-디메틸-3-(β'β-디클로로비닐)-시클로프로판 카복실레이트 함유 유인제의 제조방법
EP0391124A3 (en) Cosmetic composition of double emulsion type
DE3302898A1 (de) Emulgierendes system
PL336621A1 (en) Fluid in the form of active vitamin d3 emulsion
NO20005431D0 (no) Gelérbare farmasøytiske preparater
KR840005339A (ko) 지용성물질을 함유한 수용액의 제조방법
DE69603814D1 (de) Verwendung von Ascorbinsäure als Wirkstoff zur Behandlung von Seborrhoe in einer kosmetischen und/oder dermatologischen Zusammensetzung
ES2064801T3 (es) Emusion estable apropiada para la administracion farmaceutica, procedimiento para su obtencion, y emulsion para la aplicacion como medicamento.
KR900000074A (ko) 초미세 리포좀 형태의 양쪽친화성 지질의 분산 콜로이드계를 제조하는 방법
JPS5653608A (en) Emulsified stick cosmetic
JPS5716818A (en) Steroid fatty emulsion
US3119739A (en) Acetylmethyl-salicylate for pain relief
IE821089L (en) Cosmetic preparation containing o/w and w/o emulsions
DK0647129T3 (da) Præparat til topisk anvendelse
EP0048280A1 (en) Skin and nail composition containing phosphate-trialkanolamine complex
FR2681247B1 (fr) Composition pharmaceutique pour application topique contenant du dithranol et procede de preparation.
RU2036640C1 (ru) Мазь для лечения заболеваний с нарушением керотинизации и целостности кожи
JPH06321732A (ja) 牛乳を含むｏ／ｗ型エマルジョン化粧料組成物
SE9402455L (sv) Biskiktspreparat
SE9402454L (sv) Olja-i-vatten-emulsioner

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment